MARK GARRY: Open Payments
NPI 1235193418 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 10 payments from 5 companies in 2025. Trend: 2023 $91 · 2024 $124 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: ARISTADA, CAPLYTA, Jornay PM, REXULTI, AUSTEDO XR.
Industry payments across SD — which companies pay providers there.
